Rasmi Ranjan Sahoo

Rasmi Ranjan Sahoo

Auto-generated profile, based on publicly available information

Rasmi Ranjan Sahoo

Department of Clinical Immunology and Rheumatology, King George's Medical University, Lucknow, Uttar Pradesh, India

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2021 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
KHKasturi Hazarika
Kasturi Hazarika
RSRasmi Ranjan Sahoo
Rasmi Ranjan Sahoo
NMNamita Mohindra
Namita Mohindra
AWArchana Wakhlu
Archana Wakhlu
MMManesh Manoj
Manesh Manoj
AWAnupam Wakhlu
Anupam Wakhlu

10 February 2022 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
RSRasmi Ranjan Sahoo
Rasmi Ranjan Sahoo
AWAnupam Wakhlu
Anupam Wakhlu
VAVikas Agarwal
Vikas Agarwal

7 February 2022 in ACR Open Rheumatology
Verified
Journal Article
Open access
PDF file
RSRasmi Ranjan Sahoo
Rasmi Ranjan Sahoo
AWAnupam Wakhlu
Anupam Wakhlu
Click on the article title to read more.

23 April 2021 in Rheumatology Advances in Practice
Verified
Journal Article
Open access
PDF file
CKChengappa Kavadichanda
Chengappa Kavadichanda
VSVineeta Shobha
Vineeta Shobha
PGParasar Ghosh
Parasar Ghosh
AWAnupam Wakhlu
Anupam Wakhlu
DBDevender Bairwa
Devender Bairwa
PSPadmanabha Shenoy
Padmanabha Shenoy
Objectives: The aim was to determine the impact of the coronavirus disease 2019 (COVID-19) pandemic on access to health care among patients with scleroderma and to analyse the economic and psychosocial impacts and the infection prevention measures taken by them during the pandemic. Methods: A 25-item questionnaire designed to assess the components of the objectives was tele-administered between October 2020 and January 2021 to the patients enrolled in the Indian Progressive Systemic Sclerosis Registry. Results: Of the 428 patients in the registry, 336 took part in the study. A scheduled outpatient visit was missed by 310 (92.3%) patients, and 75 (22.3%) skipped prescription drugs. During the pandemic, 75 (22.3%) had a family member lose a job. Financial difficulties were reported by 155 (46.1%), with 116 (34.5%) patients having to spend an additional INR 4000 (2000–10 000) [USD 54.9 (27.0–137.4)] to continue treatment. Although 35 patients (10.4%) had at least one symptom suggestive of COVID-19, infection was confirmed in only 4. None of them needed hospitalization or had adverse outcomes. Worsening of scleroderma was seen in 133 (39.6%) individuals, with 15 (4.5%) requiring hospitalization. Most (96%) of the patients were aware of infection prevention measures, and 91 (27.1%) had taken unproven prophylactic medications. Conclusion: Individuals with scleroderma in India have been affected during the pandemic owing to closure of hospital services, lack of transport, loss of jobs and the additional financial burden. Health-care providers should continue to educate patients to stay on their medications and encourage them to be vaccinated for COVID-19.

19 January 2022 in BMJ Case Reports
Verified
Journal Article
Open access
PDF file
KCKunal Chandwar
Kunal Chandwar
RSRasmi Ranjan Sahoo
Rasmi Ranjan Sahoo
AWAnupam Wakhlu
Anupam Wakhlu
AWArchana Wakhlu
Archana Wakhlu

19 April 2021 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
KHKasturi Hazarika
Kasturi Hazarika
RSRasmi Ranjan Sahoo
Rasmi Ranjan Sahoo
DEDigvijay Ekbote
Digvijay Ekbote
ADAjai Kumar Dixit
Ajai Kumar Dixit
RMRungmei S Marak
Rungmei S Marak
AWAnupam Wakhlu
Anupam Wakhlu
Central nervous system nocardiosis is a rare, life-threatening infection seen commonly in immunocompromised individuals. Nocardia neocaledoniensis is a novel species seldom causing infections in humans. We describe a patient of sarcoidosis on immunosuppression, who presented with altered sensorium due to a frontal lobe abscess secondary to N. neocaledoniensis infection. Despite appropriate and adequate antibiotic coverage, and timely surgical intervention, the patient succumbed to her illness on day 6 of hospitalisation. This case warrants the consideration of novel infections in patients on immunosuppression and the need for aggressive management.